行情

MTFB

MTFB

Motif Bio
NASDAQ

实时行情|Nasdaq Last Sale

0.1539
-0.0060
-3.77%
已收盘, 17:47 11/21 EST
开盘
0.1798
昨收
0.1599
最高
0.1798
最低
0.1500
成交量
702
成交额
--
52周最高
11.50
52周最低
0.1269
市值
5,269.81万
市盈率(TTM)
-3.8757
分时
5日
1月
3月
1年
5年

分析师评级

2位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

EPS

MTFB 新闻

  • 消费和出口推动德国经济恢复增长 勉强避免陷入衰退
  • 环球外汇网官网.6小时前
  • 印度出售国有资产努力实现财政赤字目标
  • 新华网.6小时前
  • 前美联储主席耶伦:美国经济衰退风险正在积聚
  • 环球外汇网官网.6小时前
  • 连续34个月增长 日本10月消费者物价指数上升0.4%
  • 中国新闻网.6小时前

更多

所属板块

生物技术和医学研究
-0.31%
制药与医学研究
+0.39%

热门股票

名称
价格
涨跌幅

MTFB 简况

Motif Bio plc is a clinical-stage biopharmaceutical company. The Company is engaged in development of antibiotics, which are designed for treatment of infections caused by multi-drug resistant bacteria. It operates in the development and commercialization of pharmaceutical formulations segment. The Company is focused on development of its product, Iclaprim, for the treatment of the bacterial infections, such as acute bacterial skin and skin structure infections (ABSSSI) and hospital acquired bacterial pneumonia (HABP), including those caused by resistant strains, such as methicillin-resistant Staphylococcus aureus (MRSA) and multi-drug resistant Streptococcus pneumonia (MDRSP). Iclaprim exhibits potent activity against Gram-positive clinical isolates of various genera of staphylococci. It intends to build a portfolio of antibiotics by licensing drug candidates from organizations specializing in antibacterial research, and is pursuing programs in various stages of development.
展开

Webull提供Motif Bio PLC的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。